Retinitis pigmentosa

Disease1 paper

Trial sponsors

National Eye Institute
3 trialsPhase 318 people
Johns Hopkins University
2 trialsPhase 3515 people
Carol Weigel DiFranco
1 trialPhase 3221 people
Zhongshan Ophthalmic Center, Sun Yat-sen University
1 trialPhase 3126 people
Rafic Hariri University Hospital
1 trialPhase 250 people
Sun Yat-sen University
1 trialPhase 235 people
Suzhou UgeneX Therapeutics Co., Ltd.
1 trialPhase 112 people

Latest

2

Biotechnology JournalReview26 Sep

Stem Cell-Based Strategies for Retinal Cell Restoration

Preprints.orgReviewPreprint11 Sep

Epitalon and Epithalamin in Regenerative and Longevity Medicine: Mechanisms, Evidence, and Translational Gaps